Literature DB >> 11211942

Involvement of mu-calpain in human sperm capacitation for fertilization.

T Aoyama1, Y Ozaki, K Aoki, M Kunimatsu, T Tada, M Sasaki, K Suzumori.   

Abstract

PROBLEM: The distribution and physiological role of calpains in human sperm were investigated. METHOD OF STUDY: Semen collected manually from healthy donors was liquefied then centrifuged by percoll gradient centrifugation. After exposure to different concentrations of Ca2+ ionophore A23187, the samples were used for immunostaining sodium dodecyl sulfate polyacrylamide gel electrophoresis, and western blot analysis. It was speculated from the results of the study using calpain-specific inhibitors that calpain contributes to the sperm motility and acrosome reaction.
RESULTS: With the anti-pro mu-calpain antibody, sperm were immunostained, whereas all were negative for anti-pro mu-calpain antibody binding. Stained sperm were classified into four types according to the staining pattern: acrosome type, equatorial segment type, whole head type, and neck and tail segments type. Western blot analysis of sperm homogenate revealed a single 80-kDa band using the anti-pro mu-calpain antibody, its dose-dependent reduction with Ca2+ ionophore A23187 suggesting activation by this treatment. In the presence of membrane permeable calpain inhibitors, sperm motility and acrosome reaction were significantly suppressed.
CONCLUSION: These results indicate that mu-calpain may play pivotal roles in the process of fertilization of human sperm.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11211942     DOI: 10.1111/j.8755-8920.2001.450103.x

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  1 in total

1.  Association of Smoking With Semen Quality and µ-Calpain Level in Normospermia: A Case-Control Study.

Authors:  Damoon Ashtary-Larky; Mohammad Ali Ghaffari; Mozhgan Noorbehbahani; Meysam Alipour
Journal:  J Family Reprod Health       Date:  2016-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.